Economic Liberties Supports Senate Banking Democrats Demand for Hearing on Trump’s Use of Emergency Powers to Impose Incoherent Tariffs and Rejects Grassley-Cantwell Bill
April 8, 2025 – Today, as U.S. Senator Elizabeth Warren (D-Mass.), Ranking Member of the Senate Banking, Housing, and Urban Affairs Committee, led Committee Democrats in calling on Chairman Tim Scott (R-S.C.), to convene a hearing on President Trump’s use of the International Emergency Economic Powers Act (IEEPA) to impose tariffs, the American Economic Liberties Project’s Executive Director, Nidhi Hegde, released the following statement.
Competition Advocates Urge Justice, Banking Regulators to Block Capital One-Discover Merger
April 4, 2025 – Today, American Economic Liberties Project, Americans for Financial Reform Education Fund, National Community Reinvestment Coalition, and Public Citizen sent a letter to the U.S. Department of Justice, the Federal Reserve Board, and the Office of the Comptroller of the Currency (OCC) urging them to block the proposed Capital One-Discover merger under federal antitrust and banking statutes.
DOJ Approval of Capital One-Discover Would be a Shocking Wall Street Giveaway
April 3, 2025 – In response to a report that the Department of Justice Antitrust Division will decline to challenge Capital One’s proposed $35 billion acquisition of Discover Financial Services, the American Economic Liberties Project released the following statement.
Tariffs Are Vital Tool to Rebalance U.S. Trade, but Trump Must Act Immediately to Stop Corporations from Using New Tariffs as Cover to Price-Gouge
April 2, 2025 – Today, as the Trump administration announces its tariffs plan, American Economic Liberties Project’s Rethink Trade Director, Lori Wallach, released this statement.
Attempted Firings Jeopardize Critical FTC Lawsuit Against ‘Big Three’ PBMs
April 2, 2025 – In response to the news that the Federal Trade Commission (FTC) has paused its lawsuit against the three largest pharmacy benefit managers (PBMs) for engaging in an allegedly illegal rebate scheme that inflated insulin list prices, the American Economic Liberties Project released the following statement.